» Articles » PMID: 11270667

Technology and Effect: HIV/AIDS Testing in Brazil

Overview
Specialty Social Sciences
Date 2001 Mar 29
PMID 11270667
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Contemporary techno-scientific and medical developments are restructuring social interactions and the very processes by which individual subjectivity is formed. This essay elaborates on the experiential and ethical impact of such transformations from the perspective of people who, in ordinary and unexpected ways, act science and technology out. We carried out ethnographic research in an HIV/AIDS Testing and Counseling Center (CTA) in northeastern Brazil, combining participant observation with epidemiological analyses and clinical survey. We found a high demand for free testing by low-risk clients, largely working and middle class, experiencing anxiety and complaining of AIDS-like symptoms. Most of the clients were sero-negative and many returned for a second and third testing. We understand this to be a new techno-cultural phenomenon and call it imaginary AIDS. Throughout this essay, we describe CTA's routine practices, place these practices in historical, political, economic and cross-cultural perspective, and analyze the subjective data we collected from the clients of our pilot study. We explore how clinical epidemiological expertise and HIV testing technology are integrated into new forms of bio-politics aimed at specific marketable and disease-free populations, and on the affective absorption of bio-technical truth and the engendering of a technoneurosis in this testing center.

Citing Articles

Who We Test For: Aligning Relational and Public Health Responsibilities in COVID-19 Testing in Scotland.

Bevan I, Bauld L, Street A Med Anthropol. 2024; 43(4):277-294.

PMID: 38713821 PMC: 11104742. DOI: 10.1080/01459740.2024.2349514.


Institutional context and VCT practitioner narratives: possibilities and limitations for HIV prevention in Rio de Janeiro, Brazil.

Mora C, Monteiro S, Moreira C BMC Int Health Hum Rights. 2017; 17(1):31.

PMID: 29202754 PMC: 5715632. DOI: 10.1186/s12914-017-0139-x.


Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis.

Fiereck K Dev World Bioeth. 2013; 15(1):27-39.

PMID: 24373050 PMC: 4067472. DOI: 10.1111/dewb.12034.


Exploring the Ethics of Observational Research: The Case of an HIV Study in Tanzania.

Norris A, Jackson A, Khoshnood K AJOB Prim Res. 2013; 3(4):30-39.

PMID: 24069546 PMC: 3779918. DOI: 10.1080/21507716.2012.714836.


Biomarkers, the molecular gaze and the transformation of cancer survivorship.

Bell K Biosocieties. 2013; 8(2):124-143.

PMID: 23750174 PMC: 3671370. DOI: 10.1057/biosoc.2013.6.


References
1.
Kitayaporn D, Kaewkungwal J, Bejrachandra S, Rungroung E, Chandanayingyong D, Mastro T . Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand. AIDS. 1996; 10(10):1157-62. View

2.
Higgins D, Galavotti C, OReilly K, Schnell D, Moore M, Rugg D . Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991; 266(17):2419-29. View

3.
Horsburgh Jr C, Ou C, Jason J, Holmberg S, Longini Jr I, Schable C . Duration of human immunodeficiency virus infection before detection of antibody. Lancet. 1989; 2(8664):637-40. DOI: 10.1016/s0140-6736(89)90892-1. View

4.
Lackritz E, Satten G, Aberle-Grasse J, Dodd R, Raimondi V, Janssen R . Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med. 1995; 333(26):1721-5. DOI: 10.1056/NEJM199512283332601. View

5.
Barata . [Clinical epidemiology: a new medical ideology?]. Cad Saude Publica. 1996; 12(4):555-560. DOI: 10.1590/s0102-311x1996000400016. View